U.S. Clinical Trial Imaging Market Size, Share & Trends Analysis Report By Services (Clinical Trial Design & Consultation Services, Reading, & Analytical Services), By Modality (CT, MRI, X-Ray), By Application (NASH, CKD, Diabetes), By End-use, And Segment Forecasts, 2024 - 2030

Table of Contents

Chapter 1. Methodology and Scope
                   1.1. Market Segmentation & Scope
                       1.1.1. Service
                       1.1.2. Modality
                       1.1.3. Application
                       1.1.4. End Use
                       1.1.5. Estimates and forecast timeline
                   1.2. Research Methodology
                   1.3. Information Procurement
                       1.3.1. Purchased database
                       1.3.2. GVR’s internal database
                       1.3.3. Secondary sources
                       1.3.4. Primary research
                       1.3.5. Details of primary research
                   1.4. Information or Data Analysis
                       1.4.1. Data analysis models
                   1.5. Market Formulation & Validation
                   1.6. Model Details
                       1.6.1. Commodity flow analysis (Model 1)
                           1.6.1.1. Approach 1: Commodity flow approach
                       1.6.2. Volume price analysis (Model 2)
                           1.6.2.1. Approach 2: Volume price analysis
                   1.7. List of Secondary Sources
                   1.8. List of Primary Sources
                   1.9. Objectives
                       1.9.1. Objective 1
                       1.9.2. Objective 2
Chapter 2. Executive Summary
                   2.1. Market Outlook
                   2.2. Segment Outlook
                       2.2.1. Service outlook
                       2.2.2. Modality outlook
                       2.2.3. Application outlook
                       2.2.4. End use outlook
                   2.3. Competitive Insights
Chapter 3. Clinical Trial Imaging Market Variables, Trends & Scope
                   3.1. Market Lineage Outlook
                       3.1.1. Parent market outlook
                       3.1.2. Related/ancillary market outlook
                   3.2. Penetration & Growth Prospect Mapping
                   3.3. Industry Value Chain Analysis
                       3.3.1. Reimbursement framework
                   3.4. Market Dynamics
                       3.4.1. Market driver analysis
                           3.4.1.1. Growing number of pharmaceutical and biotechnological companies
                           3.4.1.2. Growing number of contract research organization (CRO)
                           3.4.1.3. Increasing research and development investments
                       3.4.2. Market restraint analysis
                           3.4.2.1. High cost of machineries and installations
                   3.5. X-ray Systems Market Analysis Tools
                       3.5.1. Industry Analysis - Porter’s Five Forces
                           3.5.1.1. Supplier power
                           3.5.1.2. Buyer power
                           3.5.1.3. Substitution threat
                           3.5.1.4. Threat of new entrant
                           3.5.1.5. Competitive rivalry
                       3.5.2. PESTEL Analysis
                           3.5.2.1. Political landscape
                           3.5.2.2. Technological landscape
                           3.5.2.3. Economic landscape
                       3.5.3. Major Deals & Strategic Alliances Analysis
                       3.5.4. Market Entry Strategies
Chapter 4. U.S. Clinical Trial Imaging Market: Service Estimates & Trend Analysis
                   4.1. Definitions and Scope
                       4.1.1. Clinical Trial Design and Consultation Services
                       4.1.2. Reading and Analytical Services
                       4.1.3. Operational Imaging
                           4.1.3.1. Computed Tomography (CT) Scan
                           4.1.3.2. MRI (Magnetic Resonance Imaging)
                           4.1.3.3. X-ray
                           4.1.3.4. Ultrasound
                           4.1.3.5. Optical Coherence Tomography (OCT)
                           4.1.3.6. Others
                       4.1.4. System and Technology Support Services
                       4.1.5. Project and Data Management
                   4.2. Services Market Share, 2018 & 2030
                   4.3. Segment Dashboard
                   4.4. U.S. Clinical Trial Imaging Market by Service Outlook
                   4.5. U.S. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
                       4.5.1. Clinical Trial Design and Consultation Services
                           4.5.1.1. Clinical Trial Design and Consultation Services market estimates and forecast 2018 to 2030 (USD Million)
                       4.5.2. Reading and Analytical Services
                           4.5.2.1. Reading and Analytical Services market estimates and forecast 2018 to 2030 (USD Million)
                       4.5.3. Operational Imaging Services
                           4.5.3.1. Operational Imaging Services market estimates and forecast 2018 to 2030 (USD Million)
                       4.5.4. System and Technology Support Services
                           4.5.4.1. System and Technology Support Services market estimates and forecast 2018 to 2030 (USD Million)
                       4.5.5. Project and Data Management
                           4.5.5.1. Project and Data Management market estimates and forecast 2018 to 2030 (USD Million)
Chapter 5. U.S. Clinical Trial Imaging Market: Modality Estimates & Trend Analysis
                   5.1. Definitions and Scope
                       5.1.1. Computed Tomography
                       5.1.2. Magnetic Resonance Imaging
                       5.1.3. X-Ray
                       5.1.4. Ultrasound
                       5.1.5. Optical Coherence Tomography (OCT)
                       5.1.6. Others
                   5.2. Modality Market Share, 2018& 2030
                   5.3. Segment Dashboard
                   5.4. U.S. Clinical Trial Imaging Market by Modality Outlook
                   5.5. U.S. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
                       5.5.1. Computed Tomography
                           5.5.1.1. Computed tomography estimates and forecast 2018 to 2030 (USD Million)
                       5.5.2. Magnetic Resonance Imaging
                           5.5.2.1. Magnetic resonance imaging estimates and forecast 2018 to 2030 (USD Million)
                       5.5.3. X-Ray
                           5.5.3.1. X-Ray market estimates and forecast 2018 to 2030 (USD Million)
                       5.5.4. Ultrasound
                           5.5.4.1. Ultrasound market estimates and forecast 2018 to 2030 (USD Million)
                       5.5.5. Optical Coherence Tomography (OCT)
                           5.5.5.1. Optical coherence tomography (OCT) market estimates and forecast 2018 to 2030 (USD Million)
                       5.5.6. Others
                           5.5.6.1. Others market estimates and forecast 2018 to 2030 (USD Million)
Chapter 6. U.S. Clinical Trial Imaging Market: Application Estimates & Trend Analysis
                   6.1. Definitions and Scope
                       6.1.1. Nonalcoholic Steatohepatitis (NASH)
                       6.1.2. Chronic Kidney Disease (CKD)
                       6.1.3. Diabetes
                       6.1.4. Cardiovascular Diseases
                       6.1.5. Ophthalmology
                       6.1.6. Musculoskeletal
                       6.1.7. Oncology
                       6.1.8. Gastroenterology
                       6.1.9. Pediatrics
                       6.1.10. Others
                   6.2. Application Market Share, 2018& 2030
                   6.3. Segment Dashboard
                   6.4. U.S. Clinical Trial Imaging Market by Application Outlook
                   6.5. U.S. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
                       6.5.1. Nonalcoholic Steatohepatitis (NASH)
                           6.5.1.1. Nonalcoholic steatohepatitis estimates and forecast 2018 to 2030 (USD Million)
                       6.5.2. Chronic Kidney Disease
                           6.5.2.1. Chronic kidney disease estimates and forecast 2018 to 2030 (USD Million)
                       6.5.3. Diabetes
                           6.5.3.1. Diabetes market estimates and forecast 2018 to 2030 (USD Million)
                       6.5.4. Cardiovascular Diseases
                           6.5.4.1. Cardiovascular diseases market estimates and forecast 2018 to 2030 (USD Million)
                       6.5.5. Ophthalmology
                           6.5.5.1. Ophthalmology market estimates and forecast 2018 to 2030 (USD Million)
                       6.5.6. Oncology
                           6.5.6.1. Oncology market estimates and forecast 2018 to 2030 (USD Million)
                       6.5.7. Musculoskeletal
                           6.5.7.1. Musculoskeletal market estimates and forecast 2018 to 2030 (USD Million)
                       6.5.8. Gastroenterology
                           6.5.8.1. Gastroenterology market estimates and forecast 2018 to 2030 (USD Million)
                       6.5.9. Pediatrics
                           6.5.9.1. Pediatrics market estimates and forecast 2018 to 2030 (USD Million)
                       6.5.10. Others
                           6.5.10.1. Others market estimates and forecast 2018 to 2030 (USD Million)
Chapter 7. U.S. Clinical Trial Imaging Market: End Use Estimates & Trend Analysis
                   7.1. Definitions and Scope
                       7.1.1. Biotechnology and Pharmaceutical Companies
                       7.1.2. Medical Devices Manufacturers
                       7.1.3. Academic and Government Research Institutes
                       7.1.4. Contract Research Organization (CRO)
                       7.1.5. Others
                   7.2. End Use Market Share, 2018 & 2030
                   7.3. Segment Dashboard
                   7.4. U.S. Clinical Trial Imaging Market by End Use Outlook
                   7.5. U.S. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
                       7.5.1. Biotechnology and Pharmaceutical Companies
                           7.5.1.1. Biotechnology and pharmaceutical companies estimates and forecast 2018 to 2030 (USD Million)
                       7.5.2. Medical Devices Manufacturers
                           7.5.2.1. Medical devices manufacturers estimates and forecast 2018 to 2030 (USD Million)
                       7.5.3. Academic and Government Research Institutes
                           7.5.3.1. Academic and government research institutes market estimates and forecast 2018 to 2030 (USD Million)
                       7.5.4. Contract Research Organization (CRO)
                           7.5.4.1. Contract research organization (CRO) market estimates and forecast 2018 to 2030 (USD Million)
                       7.5.5. Others
                           7.5.5.1. Others market estimates and forecast 2018 to 2030 (USD Million)
Chapter 8. Competitive Landscape
                   8.1. Recent Developments & Impact Analysis, By Key Market Participants
                   8.2. Company/Competition Categorization
                       8.2.1. Innovators
                   8.3. Vendor Landscape
                       8.3.1. List of key distributors and channel partners
                       8.3.2. Key customers
                       8.3.3. Key company market share analysis, 2023
                       8.3.4. IXICO plc
                           8.3.4.1. Company overview
                           8.3.4.2. Financial performance
                           8.3.4.3. Product benchmarking
                           8.3.4.4. Strategic initiatives
                       8.3.5. Navitas Life Sciences
                           8.3.5.1. Company overview
                           8.3.5.2. Financial performance
                           8.3.5.3. Product benchmarking
                           8.3.5.4. Strategic initiatives
                       8.3.6. Resonance Health
                           8.3.6.1. Company overview
                           8.3.6.2. Financial performance
                           8.3.6.3. Product benchmarking
                           8.3.6.4. Strategic initiatives
                       8.3.7. ProScan Imaging
                           8.3.7.1. Company overview
                           8.3.7.2. Financial performance
                           8.3.7.3. Product benchmarking
                           8.3.7.4. Strategic initiatives
                       8.3.8. Radiant Sage LLC
                           8.3.8.1. Company overview
                           8.3.8.2. Financial performance
                           8.3.8.3. Product benchmarking
                           8.3.8.4. Strategic initiatives
                       8.3.9. Medpace
                           8.3.9.1. Company overview
                           8.3.9.2. Financial performance
                           8.3.9.3. Product benchmarking
                           8.3.9.4. Strategic initiatives
                       8.3.10. Biomedical Systems Corp.
                           8.3.10.1. Company overview
                           8.3.10.2. Financial performance
                           8.3.10.3. Product benchmarking
                           8.3.10.4. Strategic initiatives
                       8.3.11. Cardiovascular Imaging Technologies
                           8.3.11.1. Company overview
                           8.3.11.2. Financial performance
                           8.3.11.3. Product benchmarking
                           8.3.11.4. Strategic initiatives
                       8.3.12. Intrinsic Imaging
                           8.3.12.1. Company overview
                           8.3.12.2. Financial performance
                           8.3.12.3. Product benchmarking
                           8.3.12.4. Strategic initiatives
                       8.3.13. BioTelemetry
                           8.3.13.1. Company overview
                           8.3.13.2. Financial performance
                           8.3.13.3. Product benchmarking
                           8.3.13.4. Strategic initiatives

List of Tables

Table 1 List of Abbreviations
Table 2 U.S. clinical trial imaging market, by service, 2018 - 2030 (USD Million)
Table 3 U.S. clinical trial imaging market, by modality, 2018 - 2030 (USD Million)
Table 4 U.S. clinical trial imaging market, by application, 2018 - 2030 (USD Million)
Table 5 U.S. clinical trial imaging market, by end use, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 clinical trial imaging market: market outlook
Fig. 9 clinical trial imaging market competitive insights
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook
Fig. 12 Penetration and growth prospect mapping
Fig. 13 Industry value chain analysis
Fig. 14 Clinical trial imaging market driver impact
Fig. 15 Clinical trial imaging market restraint impact
Fig. 16 Clinical trial imaging market strategic initiatives analysis
Fig. 17 Clinical trial imaging market: Service movement analysis
Fig. 18 Clinical trial imaging market: Service outlook and key takeaways
Fig. 19 Clinical trial design and consultation services market estimates and forecast, 2018 - 2030
Fig. 20 Reading and analytical services market estimates and forecast, 2018 - 2030
Fig. 21 Operational imaging services market estimates and forecast, 2018 - 2030
Fig. 22 System and technology support services market estimates and forecast, 2018 - 2030
Fig. 23 Project and data management market estimates and forecast, 2018 - 2030
Fig. 24 Clinical trial imaging market: Modality movement analysis
Fig. 25 Clinical trial imaging market: Modality outlook and key takeaways
Fig. 26 Computed tomography market estimates and forecast, 2018 - 2030
Fig. 27 Magnetic resonance imaging market estimates and forecast, 2018 - 2030
Fig. 28 X-Ray market estimates and forecast, 2018 - 2030
Fig. 29 Ultrasound market estimates and forecast, 2018 - 2030
Fig. 30 Optical coherence tomography (OCT) market estimates and forecast, 2018 - 2030
Fig. 31 Others market estimates and forecast, 2018 - 2030
Fig. 32 Clinical trial imaging market: Application movement analysis
Fig. 33 Clinical trial imaging market: Application outlook and key takeaways
Fig. 34 NASH market estimates and forecast, 2018 - 2030
Fig. 35 CKD market estimates and forecast, 2018 - 2030
Fig. 36 Diabetes market estimates and forecast, 2018 - 2030
Fig. 37 Cardiovascular diseases market estimates and forecast, 2018 - 2030
Fig. 38 Ophthalmology market estimates and forecast, 2018 - 2030
Fig. 39 Musculoskeletal market estimates and forecast, 2018 - 2030
Fig. 40 Oncology market estimates and forecast, 2018 - 2030
Fig. 41 Gastroenterology market estimates and forecast, 2018 - 2030
Fig. 42 Pediatrics market estimates and forecast, 2018 - 2030
Fig. 43 Others market estimates and forecast, 2018 - 2030
Fig. 44 Clinical trial imaging market: End use movement analysis
Fig. 45 Clinical trial imaging market: End use outlook and key takeaways
Fig. 46 Biotechnology and Pharmaceutical companies market estimates and forecast, 2018 - 2030
Fig. 47 Medical devices manufacturers market estimates and forecast, 2018 - 2030
Fig. 48 Academic and government research institutes market estimates and forecast, 2018 - 2030
Fig. 49 Contract research organizations (CROs) market estimates and forecast, 2018 - 2030
Fig. 50 Others market estimates and forecast, 2018 - 2030
Fig. 51 Participant categorization- Clinical trial imaging market
Fig. 52 Market share of key market players- Clinical trial imaging market